G
Gideon Nesher
Researcher at Shaare Zedek Medical Center
Publications - 110
Citations - 3937
Gideon Nesher is an academic researcher from Shaare Zedek Medical Center. The author has contributed to research in topics: Giant cell arteritis & Polymyalgia rheumatica. The author has an hindex of 35, co-authored 105 publications receiving 3645 citations. Previous affiliations of Gideon Nesher include Hebrew University of Jerusalem & Saint Louis University.
Papers
More filters
Journal ArticleDOI
Low‐dose aspirin and prevention of cranial ischemic complications in giant cell arteritis
TL;DR: It is suggested that low-dose aspirin decreases the rate of visual loss and CVAs in patients with GCA, and despite the use of steroid therapy, cranial ischemic complications developed in 14 of the 166 patients followed up for 3 months or longer.
Journal ArticleDOI
Seronegative Lyme Disease
David A. Relman,Gideon Nesher,T G Osborn,Terry L. Moore,Felix Mor,Leonard Leibovici,Raymond J. Dattwyler,David J. Volkman,Benjamin J. Luft,John J. Halperin,Josephine A. Thomas,Marc G. Golightly +11 more
TL;DR: It is concluded that the presence of chronic Lyme disease cannot be excluded by the absence of antibodies against B. burgdorferi and that a specific T-cell blastogenic response to the spirochete is evidence of infection in seronegative patients with clinical indications of Chronic Lyme disease.
Journal ArticleDOI
Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment.
TL;DR: This work describes four patients and their dramatic clinical and hemodynamic response to treatment with prednisone when symptomatic measures failed and a novel approach for symptomatic antiphospholipid syndrome (APS) related valvulopathy involves treatment with systemic corticosteroid.
Journal Article
Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients.
TL;DR: Steroid treatment in TA may cause major morbidity and increased mortality, the therapeutic regimen in TA should be individualized, and the patient's age, severity of TA, and coexistent medical conditions should be considered.
Journal ArticleDOI
Thrombotic microangiopathic hemolytic anemia in systemic lupus erythematosus
TL;DR: It is suggested that TMHA should be considered in any SLE patient presenting with neurological symptoms or renal failure associated with fever, hemolytic anemia, and thrombocytopenia, and early recognition and appropriate therapy with plasmapheresis may improve prognosis.